Latest PHAS reports update at 2022-08-12: 2022-Q22022-Q12021-Q4
PhaseBio Pharmaceuticals logo
PhaseBio Pharmaceuticals PHAS
$ 0.13 7.4%

PhaseBio Pharmaceuticals Cash Flow 2011-2024 | PHAS

Annual Cash Flow PhaseBio Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

-47.4 M -60 M -39.6 M -17.1 M -8.26 M - - - - - -

Depreciation & Amortization

1.79 M 508 K 174 K 105 K 96 K - - - - - -

Accounts Payables

12.6 M 3.67 M 2.92 M 1.81 M - - - - - - -

Accounts Receivables

- - - - - - - - - - -

Total Inventories

- - - - - - - - - - -

All numbers in USD currency

Quarterly Cash Flow PhaseBio Pharmaceuticals

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

- - -33.3 M -22.9 M - - -21.3 M -10.2 M - -48.6 M -32.8 M -23.8 M - -27.1 M -18.9 M -8.73 M - -10.2 M -6.64 M -2.63 M - -5.84 M - - - - - - - - - - - - - - - - - - - - - - - - - -

Depreciation & Amortization

- - 1.2 M 601 K - 100 K 1.06 M 474 K - 166 K 111 K 54 K - 124 K 74 K 31 K - 82 K 54 K 27 K - 68 K - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Payables

- - 6.32 M 6.78 M 12.6 M 8.52 M 2.96 M 5.9 M 3.67 M 3.67 M 3.67 M 3.67 M 2.92 M 2.92 M 2.92 M 2.92 M 1.81 M 1.81 M 1.81 M 1.81 M 430 K 430 K - - - - - - - - - - - - - - - - - - - - - - - - - -

Accounts Receivables

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Inventories

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency